Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Melisa L. Wong"'
Autor:
Lisa Morse, Bruce A. Cooper, Christine S. Ritchie, Melisa L. Wong, Kord M. Kober, Carolyn Harris, Joosun Shin, Kate Oppegaard, Marilyn J. Hammer, Alejandra Calvo Schimmel, Steven M. Paul, Yvette P. Conley, Jon D. Levine, Christine Miaskowski
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background By 2035, the number of newly diagnosed cancer cases will double and over 50% will be in older adults. Given this rapidly growing demographic, a need exists to understand how age influences oncology patients’ symptom burden. The
Externí odkaz:
https://doaj.org/article/325bcc69780f44e69e53740841d9bceb
Autor:
Jingran Ji, MD, Jacqueline V. Aredo, MD, MS, Andrew Piper-Vallillo, MD, Laura Huppert, MD, Julia K. Rotow, MD, Hatim Husain, MD, Susan Stewart, PhD, Rosemary Cobb, BS, Heather A. Wakelee, MD, Collin M. Blakely, MD, PhD, Melisa L. Wong, MD, MAS, Matthew A. Gubens, MD, MS, Mohammad H. Madani, MD, Subba R. Digumarthy, MD, Caroline McCoach, MD, PhD, Zofia Piotrowska, MD, MHS, Joel W. Neal, MD, PhD, Jonathan W. Riess, MD, MS
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 3, Pp 100459- (2023)
Introduction: EGFR mutations drive a subset of NSCLC. Patients harboring the common EGFR mutations, deletion of exon 19 and L858R, respond well to osimertinib, a third-generation tyrosine kinase inhibitor. Nevertheless, the effect of osimertinib on N
Externí odkaz:
https://doaj.org/article/0cd8922ebf5946adba6b0fb71a9d9100
Autor:
Carolyn J. Presley, MD, MHS, Nicole A. Arrato, MA, Peter G. Shields, MD, David P. Carbone, MD, PhD, Melisa L. Wong, MD, MAS, Jason Benedict, MS, Sarah A. Reisinger, PhD, MPH, Ling Han, MD, PhD, Thomas M. Gill, MD, Heather Allore, PhD, Barbara L. Andersen, PhD, Sarah Janse, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 6, Pp 100334- (2022)
Introduction: To evaluate whether and the degree to which patients with advanced NSCLC (aNSCLC) receiving lung cancer treatments will experience functional disability or have resilience and to identify characteristics associated with functional disab
Externí odkaz:
https://doaj.org/article/84faa37665c74d2f8168f0438710b653
Autor:
Carolyn J. Presley, Mostafa R. Mohamed, Eva Culakova, Marie Flannery, Pooja H. Vibhakar, Rebecca Hoyd, Arya Amini, Noam VanderWalde, Melisa L. Wong, Yukari Tsubata, Daniel J. Spakowicz, Supriya G. Mohile
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionMore older adults die from lung cancer worldwide than breast, prostate, and colorectal cancers combined. Current lung cancer treatments may prolong life, but can also cause considerable treatment-related toxicity.ObjectiveThis study is a
Externí odkaz:
https://doaj.org/article/4783e850f3ea4090b9f00b9a5adc7ba6
Autor:
Joosun Shin, Kord M. Kober, Melisa L. Wong, Patsy Yates, Bruce A. Cooper, Steven M. Paul, Marilyn Hammer, Yvette Conley, Jon D. Levine, Christine Miaskowski
Publikováno v:
Journal of Pain and Symptom Management. 65:242-255
Shortness of breath is a distressing symptom that occurs in 10% to 70% of oncology patients. Despite this broad range in its occurrence, little is known about inter-individual variability in shortness of breath and associated risk factors among patie
Publikováno v:
International Journal of Cancer. 152:2283-2291
Autor:
Erin Watson, Chandrika Sanapala, Ashley-Marie Cortes, Heidi D. Klepin, Marsha Wittink, Sally Norton, Daniel R. Richardson, William Dale, Allison Magnuson, Jason H. Mendler, Jane Liesveld, Eric Huselton, Kristen O’Dwyer, Thomas W. LeBlanc, Areej El-Jawahri, Melisa L. Wong, Kah Poh Loh
Publikováno v:
Blood Advances. 6:5707-5710
Autor:
Mazie Tsang, Siqi Gan, W. John Boscardin, Melisa L. Wong, Louise C. Walter, Alexander K. Smith
Publikováno v:
Journal of the American Geriatrics Society. 70:3402-3412
Older patients with poor prognosis cancers have complex needs that can benefit from geriatrics and palliative care principles. Because they are not routinely assessed, the prevalence of preexisting geriatric and palliative conditions in this populati
Autor:
Jingran Ji, Jacqueline V. Aredo, Andrew Piper-Vallillo, Laura Huppert, Julia K. Rotow, Hatim Husain, Susan Stewart, Rosemary Cobb, Heather A. Wakelee, Collin M. Blakely, Melisa L. Wong, Matthew A. Gubens, Mohammad H. Madani, Subba R. Digumarthy, Caroline McCoach, Zofia Piotrowska, Joel W. Neal, Jonathan W. Riess
Publikováno v:
JTO clinical and research reports, vol 4, iss 3
IntroductionEGFR mutations drive a subset of NSCLC. Patients harboring the common EGFR mutations, deletion ofexon 19 and L858R, respond well to osimertinib, a third-generation tyrosine kinase inhibitor. Nevertheless, the effect of osimertinib on NSCL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b5f5bf930686fbe6ed66c658359e142
https://escholarship.org/uc/item/4t34k587
https://escholarship.org/uc/item/4t34k587
Publikováno v:
Journal of the American Geriatrics Society. 70:2209-2213
An academic career in aging research is filled with the incredible highs of important discoveries that improve the lives of older adults and repeated lows when papers and grants are rejected or studies are negative. To normalize the experience of set